Bayer builds in Germany; Aventis splits from Novartis in vax venture;

> Bayer is investing $47 million in a facility in Wuppertal, Germany, to produce experimental biologics for its clinical trials. Release

> Sanofi-Aventis unit Aventis Pharma is selling its 49 percent stake in a vaccine-making company to partner Novartis. Story

> B2B trade board sellers are positioning themselves as drop shippers and order-fulfillment centers for Internet pharmacies. Release

> According to reports, Juhel Pharmaceutical Manufacturing's managing director Ifeanyi Okoye has been kidnapped in Anambra State, Nigeria, two months after the kidnapping of his mother. Article

> The Seoul Metropolitan Police have booked 15 pharmacists for importing fake Viagra from China. Story

> The Saudi Pharmaceutical Industry & Medical Appliances Corp. is one of several companies "leading the charge" to both import and produce pharmaceutical goods and equipment in the kingdom. Story

> Recovery from a decade-long economic contraction is driving growth in Zimbabwe's pharmaceutical sector. Release

> China's Lotus Pharmaceuticals is scrapping plans to build a facility in Inner Mongolia so it can focus on its core business in Beijing. Article

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.